Cargando…
Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
Endocannabinoids participate in the control of neurogenesis, neural cell death and gliosis. The pharmacological effect of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which limits the endocannabinoid degradation, was investigated in the present study. Cell proliferation (phospho-H3(+) or...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375993/ https://www.ncbi.nlm.nih.gov/pubmed/25870539 http://dx.doi.org/10.3389/fncel.2015.00098 |
_version_ | 1782363663032647680 |
---|---|
author | Rivera, Patricia Bindila, Laura Pastor, Antoni Pérez-Martín, Margarita Pavón, Francisco J. Serrano, Antonia de la Torre, Rafael Lutz, Beat Rodríguez de Fonseca, Fernando Suárez, Juan |
author_facet | Rivera, Patricia Bindila, Laura Pastor, Antoni Pérez-Martín, Margarita Pavón, Francisco J. Serrano, Antonia de la Torre, Rafael Lutz, Beat Rodríguez de Fonseca, Fernando Suárez, Juan |
author_sort | Rivera, Patricia |
collection | PubMed |
description | Endocannabinoids participate in the control of neurogenesis, neural cell death and gliosis. The pharmacological effect of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which limits the endocannabinoid degradation, was investigated in the present study. Cell proliferation (phospho-H3(+) or BrdU(+) cells) of the main adult neurogenic zones as well as apoptosis (cleaved caspase-3(+)), astroglia (GFAP(+)), and microglia (Iba1(+) cells) were analyzed in the hippocampus, hypothalamus and striatum of rats intraperitoneally treated with URB597 (0.3 mg/kg/day) at one dose/4-days resting or 5 doses (1 dose/day). Repeated URB597 treatment increased the plasma levels of the N-acylethanolamines oleoylethanolamide, palmitoylethanolamide and arachidonoylethanolamine, reduced the plasma levels of glucose, triglycerides and cholesterol, and induced a transitory body weight decrease. The hippocampi of repeated URB597-treated rats showed a reduced number of phospho-H3(+) and BrdU(+) subgranular cells as well as GFAP(+), Iba1(+) and cleaved caspase-3(+) cells, which was accompanied with decreased hippocampal expression of the cannabinoid CB1 receptor gene Cnr1 and Faah. In the hypothalami of these rats, the number of phospho-H3(+), GFAP(+) and 3-weeks-old BrdU(+) cells was specifically decreased. The reduced striatal expression of CB1 receptor in repeated URB597-treated rats was only associated with a reduced apoptosis. In contrast, the striatum of acute URB597-treated rats showed an increased number of subventricular proliferative, astroglial and apoptotic cells, which was accompanied with increased Faah expression. Main results indicated that FAAH inhibitor URB597 decreased neural proliferation, glia and apoptosis in a brain region-dependent manner, which were coupled to local changes in Faah and/or Cnr1 expression and a negative energy context. |
format | Online Article Text |
id | pubmed-4375993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-43759932015-04-13 Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context Rivera, Patricia Bindila, Laura Pastor, Antoni Pérez-Martín, Margarita Pavón, Francisco J. Serrano, Antonia de la Torre, Rafael Lutz, Beat Rodríguez de Fonseca, Fernando Suárez, Juan Front Cell Neurosci Neuroscience Endocannabinoids participate in the control of neurogenesis, neural cell death and gliosis. The pharmacological effect of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which limits the endocannabinoid degradation, was investigated in the present study. Cell proliferation (phospho-H3(+) or BrdU(+) cells) of the main adult neurogenic zones as well as apoptosis (cleaved caspase-3(+)), astroglia (GFAP(+)), and microglia (Iba1(+) cells) were analyzed in the hippocampus, hypothalamus and striatum of rats intraperitoneally treated with URB597 (0.3 mg/kg/day) at one dose/4-days resting or 5 doses (1 dose/day). Repeated URB597 treatment increased the plasma levels of the N-acylethanolamines oleoylethanolamide, palmitoylethanolamide and arachidonoylethanolamine, reduced the plasma levels of glucose, triglycerides and cholesterol, and induced a transitory body weight decrease. The hippocampi of repeated URB597-treated rats showed a reduced number of phospho-H3(+) and BrdU(+) subgranular cells as well as GFAP(+), Iba1(+) and cleaved caspase-3(+) cells, which was accompanied with decreased hippocampal expression of the cannabinoid CB1 receptor gene Cnr1 and Faah. In the hypothalami of these rats, the number of phospho-H3(+), GFAP(+) and 3-weeks-old BrdU(+) cells was specifically decreased. The reduced striatal expression of CB1 receptor in repeated URB597-treated rats was only associated with a reduced apoptosis. In contrast, the striatum of acute URB597-treated rats showed an increased number of subventricular proliferative, astroglial and apoptotic cells, which was accompanied with increased Faah expression. Main results indicated that FAAH inhibitor URB597 decreased neural proliferation, glia and apoptosis in a brain region-dependent manner, which were coupled to local changes in Faah and/or Cnr1 expression and a negative energy context. Frontiers Media S.A. 2015-03-27 /pmc/articles/PMC4375993/ /pubmed/25870539 http://dx.doi.org/10.3389/fncel.2015.00098 Text en Copyright © 2015 Rivera, Bindila, Pastor, Pérez-Martín, Pavón, Serrano, de la Torre, Lutz, Rodríguez de Fonseca and Suárez. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Rivera, Patricia Bindila, Laura Pastor, Antoni Pérez-Martín, Margarita Pavón, Francisco J. Serrano, Antonia de la Torre, Rafael Lutz, Beat Rodríguez de Fonseca, Fernando Suárez, Juan Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context |
title | Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context |
title_full | Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context |
title_fullStr | Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context |
title_full_unstemmed | Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context |
title_short | Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context |
title_sort | pharmacological blockade of the fatty acid amide hydrolase (faah) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375993/ https://www.ncbi.nlm.nih.gov/pubmed/25870539 http://dx.doi.org/10.3389/fncel.2015.00098 |
work_keys_str_mv | AT riverapatricia pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext AT bindilalaura pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext AT pastorantoni pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext AT perezmartinmargarita pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext AT pavonfranciscoj pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext AT serranoantonia pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext AT delatorrerafael pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext AT lutzbeat pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext AT rodriguezdefonsecafernando pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext AT suarezjuan pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext |